Theriva Biologics anuncia el desdoblamiento inverso de sus acciones
ROCKVILLE, Md., Aug. 17, 2024 (GLOBE NEWSWIRE) — Theriva Biologics, Inc. (NYSE American: TOVX), una empresa diversificada de fase clínica […]
UPDATE: Sol-Gel Reports Second Quarter 2024 Financial Results and Provides Corporate Updates
Following recent transactions and cost-cutting efforts, Sol-Gel’s cash runway is expected to extend into the first quarter of 2026 Ongoing […]
Acceleware Ltd. Reports Second Quarter 2024 Financial and Operating Results
CALGARY, Alberta, Aug. 17, 2024 (GLOBE NEWSWIRE) — Acceleware® Ltd. (“Acceleware” or the “Company”) (TSX-V: AXE), a leading innovator of […]
